Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endosomal Toll-like receptors (TLRs) are a subfamily of pattern recognition receptors (PRRs) that detect nucleic acids from pathogens within endosomal compartments. Key members include TLR3, TLR7, TLR8, and TLR9. Activation of these receptors triggers signaling cascades leading to the production of pro-inflammatory cytokines and type I interferons, playing a crucial role in antiviral and antibacterial immunity. However, dysregulation can contribute to autoimmune diseases like SLE. They are localized to endosome membranes and require proteolytic cleavage for full activity.
Inhibition of endosomal TLR activation via interference with receptor trafficking or acidification.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal Toll-Like Receptors (Endosomal TLRs).